Bronchiectasis in COPD patients: more than a comorbidity? [Corrigendum]
Bronchiectasis in COPD patients: more than a comorbidity? [Corrigendum]Martinez-Garcia MA, Miravitlles M. Int J Chron Obstruct Pulmon Dis. 2017;12:1401–1411.Page 1409, Disclosure, the text “The authors report no conflicts of interest in this work&rd...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2019-01-01
|
| Series: | International Journal of COPD |
| Online Access: | https://www.dovepress.com/corrigendum-bronchiectasis-in-copd-patients-more-than--peer-reviewed-article-COPD |
| _version_ | 1811196815518728192 |
|---|---|
| author | Martinez-Garcia MA Miravitlles M |
| author_facet | Martinez-Garcia MA Miravitlles M |
| author_sort | Martinez-Garcia MA |
| collection | DOAJ |
| description | Bronchiectasis in COPD patients: more than a comorbidity? [Corrigendum]Martinez-Garcia MA, Miravitlles M. Int J Chron Obstruct Pulmon Dis. 2017;12:1401–1411.Page 1409, Disclosure, the text “The authors report no conflicts of interest in this work” should read “MM has received speaker fees from Boehringer Ingelheim, Chiesi, Cipla, Menarini, Rovi, Bial, CSL Behring, Grifols and Novartis; consultancy fees from Boehringer Ingelheim, Chiesi, GlaxoSmithKline, Bial, Gebro Pharma, CSL Behring, Laboratories Esteve, Mereo BioPharma, Verona Pharma, pH Pharma, Novartis and Grifols; and research grants fromGlaxoSmithKline and Grifols. MAM has received speaker fees from Chiesi, Grifols, Novartis, TEVA and Zambon; onsultancy fees from Zambon and TEVA; and research grants from Zambon”.Read the original article |
| first_indexed | 2024-04-12T01:05:33Z |
| format | Article |
| id | doaj.art-5c085f68289a440695b2944ee0652720 |
| institution | Directory Open Access Journal |
| issn | 1178-2005 |
| language | English |
| last_indexed | 2024-04-12T01:05:33Z |
| publishDate | 2019-01-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | International Journal of COPD |
| spelling | doaj.art-5c085f68289a440695b2944ee06527202022-12-22T03:54:17ZengDove Medical PressInternational Journal of COPD1178-20052019-01-01Volume 1424524643645Bronchiectasis in COPD patients: more than a comorbidity? [Corrigendum]Martinez-Garcia MAMiravitlles MBronchiectasis in COPD patients: more than a comorbidity? [Corrigendum]Martinez-Garcia MA, Miravitlles M. Int J Chron Obstruct Pulmon Dis. 2017;12:1401–1411.Page 1409, Disclosure, the text “The authors report no conflicts of interest in this work” should read “MM has received speaker fees from Boehringer Ingelheim, Chiesi, Cipla, Menarini, Rovi, Bial, CSL Behring, Grifols and Novartis; consultancy fees from Boehringer Ingelheim, Chiesi, GlaxoSmithKline, Bial, Gebro Pharma, CSL Behring, Laboratories Esteve, Mereo BioPharma, Verona Pharma, pH Pharma, Novartis and Grifols; and research grants fromGlaxoSmithKline and Grifols. MAM has received speaker fees from Chiesi, Grifols, Novartis, TEVA and Zambon; onsultancy fees from Zambon and TEVA; and research grants from Zambon”.Read the original article https://www.dovepress.com/corrigendum-bronchiectasis-in-copd-patients-more-than--peer-reviewed-article-COPD |
| spellingShingle | Martinez-Garcia MA Miravitlles M Bronchiectasis in COPD patients: more than a comorbidity? [Corrigendum] International Journal of COPD |
| title | Bronchiectasis in COPD patients: more than a comorbidity? [Corrigendum] |
| title_full | Bronchiectasis in COPD patients: more than a comorbidity? [Corrigendum] |
| title_fullStr | Bronchiectasis in COPD patients: more than a comorbidity? [Corrigendum] |
| title_full_unstemmed | Bronchiectasis in COPD patients: more than a comorbidity? [Corrigendum] |
| title_short | Bronchiectasis in COPD patients: more than a comorbidity? [Corrigendum] |
| title_sort | bronchiectasis in copd patients more than a comorbidity corrigendum |
| url | https://www.dovepress.com/corrigendum-bronchiectasis-in-copd-patients-more-than--peer-reviewed-article-COPD |
| work_keys_str_mv | AT martinezgarciama bronchiectasisincopdpatientsmorethanacomorbiditycorrigendum AT miravitllesm bronchiectasisincopdpatientsmorethanacomorbiditycorrigendum |